0001209191-17-066110.txt : 20171218
0001209191-17-066110.hdr.sgml : 20171218
20171218160749
ACCESSION NUMBER: 0001209191-17-066110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171215
FILED AS OF DATE: 20171218
DATE AS OF CHANGE: 20171218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Payne Steven
CENTRAL INDEX KEY: 0001578733
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 171261452
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-15
0
0001237831
GLOBUS MEDICAL INC
GMED
0001578733
Payne Steven
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
0
1
0
0
Chief Accounting Officer
Class A Common Stock
2017-12-15
4
M
0
3076
4.88
A
23847
D
Class A Common Stock
2017-12-15
4
S
0
3076
39.3019
D
20771
D
Stock Option (Right to Buy Class A Common Stock)
4.88
2017-12-15
4
M
0
3076
0.00
D
2019-08-06
Class A Common Stock
3076
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.30 to $39.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Anthony L. Williams, Attorney-in-Fact
2017-12-18